The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. (2012)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.nbd.2011.12.042
PubMed Identifier: 22405424
Publication URI: http://europepmc.org/abstract/MED/22405424
Type: Journal Article/Review
Volume: 46
Parent Publication: Neurobiology of disease
Issue: 1
ISSN: 0969-9961